Exercise Type That Faster Reduces Postprandial Glycemia.
NCT ID: NCT04846751
Last Updated: 2022-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
11 participants
INTERVENTIONAL
2021-11-01
2024-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
NCT05203640
Effectiveness of Aerobic Exercise to Mitigate Hyperglycemia After Fasted Resistance Exercise
NCT05203653
Exercise and Glycemic Control in Type 2 Diabetes
NCT00945165
Hyperglycemia and Exercise.
NCT03284216
Physical Activity and Insulin Sensitivity Dynamics
NCT06776094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will undergo in a cross-over randomized fashion the following trials:
1. Exercise pedalling during 50 min at 60% of their VO2max followed by an oral glucose tolerance test (OGTT).
2. Exercise pedalling during 50 min in a hot environment (33ÂșC) at 60% of their VO2max followed by an oral glucose tolerance test (OGTT).
3. Exercise pedalling during 50 min using intervalic bouts averaging 60% of VO2max followed by an oral glucose tolerance test (OGTT).
4. No exercise, followed by an oral glucose tolerance test (OGTT).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AEROBIC EXERCISE
50 min of aerobic exercise by pedaling a cycleergometer at 60% of VO2max
TYPE OF EXERCISE (OR REST)
continous exercise in normal temperature, continous exercise in hot environment, intervallic exercise in normal temperature.
PLACEBO REST
No exercise, resting during 50 min.
TYPE OF EXERCISE (OR REST)
continous exercise in normal temperature, continous exercise in hot environment, intervallic exercise in normal temperature.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TYPE OF EXERCISE (OR REST)
continous exercise in normal temperature, continous exercise in hot environment, intervallic exercise in normal temperature.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimal fitness level to be able to complete 50 min of continous exercise at a moderate intensity.
Exclusion Criteria
* Pregnancy
* Any non-controlled medical condition which could influence results or could be worsened by exercise
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Castilla-La Mancha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo Mora
Director of the Exercise Lab at Toledo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo Mora-Rodriguez, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Castilla-La Mancha
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Castilla-La Mancha (Exercise Physiology Lab)
Toledo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PID2020-116159RB-I00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.